FP
GSK icon

Financial Perspectives’s GSK GSK Stock Holding History

Financial Perspectives’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Hold
517
– – 0.01% 418
2026
Q1 		$28.5K Hold
517
– – 0.01% 394
2025
Q4 		$25.3K Hold
517
– – 0.01% 404
2025
Q3 		$22.3K Hold
517
– – 0.01% 411
2025
Q2 		$19.8K Hold
517
– – 0.01% 418
2025
Q1 		$20K Buy
517
+3
+0.6% +$110 0.01% 414
2024
Q4 		$17.4K Buy
514
+2
+0.4% +$72 0.01% 429
2024
Q3 		$20.9K Buy
512
+2
+0.4% +$82 0.01% 385
2024
Q2 		$19.6K Buy
510
+2
+0.4% +$84 0.01% 386
2024
Q1 		$21.8K Buy
508
+2
+0.4% +$82 0.01% 369
2023
Q4 		$18.7K Buy
506
+2
+0.4% +$72 0.01% 386
2023
Q3 		$18.3K Buy
504
+3
+0.6% +$106 0.01% 369
2023
Q2 		$17.9K Buy
501
+2
+0.4% +$72 0.01% 376
2023
Q1 		$17.8K Buy
499
+1
+0.2% +$35 0.01% 373
2022
Q4 		$17.5K Buy
498
+3
+0.6% +$100 0.01% 375
2022
Q3 		$14.6K Hold
495
– – 0.01% 391
2022
Q2 		$26.9K Buy
495
+3
+0.6% +$166 0.02% 309
2022
Q1 		$26.8K Buy
492
+2
+0.4% +$109 0.01% 328
2021
Q4 		$27K Buy
490
+3
+0.6% +$156 0.01% 321
2021
Q3 		$23.3K Sell
487
-4,958
-91% -$249K 0.01% 339
2021
Q2 		$271K Sell
5,445
-188,757
-97% -$9.07M 0.13% 105
2021
Q1 		$6.8M Buy
194,202
+188,763
+3,471% +$8.57M 0.34% 50
2020
Q4 		$250K Sell
5,439
-1,597
-23% -$73.4K 0.14% 102
2020
Q3 		$331K Buy
7,036
+2
+0% +$100 0.22% 66
2020
Q2 		$359K Buy
7,034
+3
+0% +$154 0.26% 57
2020
Q1 		$333K Buy
7,031
+1
+0% +$53 0.27% 49
2019
Q4 		$413K Buy
+7,030
New +$391K 0.28% 45

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Financial Perspectives's GSK Position: Q2 2026 in Review

Financial Perspectives held its GSK (GSK) position steady in Q2 2026 at 517 shares worth $27.1K. The position accounts for 0.01% of the portfolio, ranked #418.

Financial Perspectives first reported a position in GSK in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.8M in Q1 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Financial Perspectives held 517 shares of GSK worth $27.1K as of Q2 2026.
  • Financial Perspectives left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Financial Perspectives's portfolio in Q2 2026, its #418 holding.
  • Financial Perspectives first reported a position in GSK in Q4 2019 and has held it in 27 quarters since.
  • Financial Perspectives's GSK position peaked at $6.8M in Q1 2021.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.